Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
2 mg | In stock | $ 78.00 | |
5 mg | In stock | $ 126.00 | |
10 mg | In stock | $ 198.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 515.00 | |
100 mg | In stock | $ 747.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 179.00 |
Description | Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity. |
Targets&IC50 | LSD1:0.25 nM (IC50) |
In vivo | LSD1-IN-7 in combination with other LSD1 inhibitor can be treatment of cancer in a mammal, including breast cancer, lung cancer, prostate cancer, glioblastoma, or leukemia. |
Synonyms | LSD1-IN-7 benzenesulfonate, CC-90011 benzenesulfonate |
Molecular Weight | 609.64 |
Formula | C30H29F2N5O5S |
CAS No. | 2097523-60-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60mg/ml(98.42mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pulrodemstat benzenesulfonate 2097523-60-7 Chromatin/Epigenetic Histone Demethylase LSD1 Pulrodemstat oral SCLC reversible CC-90011 cell CC90011 LSD1-IN-7 benzenesulfonate CC-90011 benzenesulfonate anticancer differentiation inhibit Inhibitor AML CC 90011 inhibitor